Dr. Tiago Reis Marques - 20 Dec 2021 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Chief Executive Officer, Director
Signature: /s/ Dr. Tiago Reis Marques
Issuer symbol: KTTA
Transactions as of: 20 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 22 Dec 2021, 16:00:09 UTC
Previous filing: 14 Sep 2021
Next filing: 23 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTTA	Common Stock	Award	$0	+200,000	+33%	$0.000000	800,000	20 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KTTA	Stock Option (to acquire Common Stock)	Award	$0	+200,000		$0.000000	200,000	20 Dec 2021	Common Stock	200,000	$1.44	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted Restricted Stock Units which shall vest into common stock of the Company over three years, subject to Dr. Marques remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches quarterly for two years thereinafter.
F2	The Reporting Person was granted 200,000 stock options. The stock options have a ten-year term and vest over three years, subject to Dr. Marques remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches quarterly for two years thereinafter.